Formulation and Evaluation of Sustained Release Tablet of an AntiDiabetic Drug Vildagliptin Using Natural Polymer

Reference

1. Mittal B. Pharmaceutical unit operations. How to Dev Robust Solid Oral Dos Forms from Concept to Post-approval; Mittal, B, Ed. 2017;69–95. 
2. Mukesh Kumar, Suryakant Verma VKS. International Journal for Pharmaceutical Research Scholars ( IJPRS ). Int J Pharm Res Sch. 2014;3(2):540–50. 
3. Zhou QT, Li T. Formulation and Manufacturing of Solid Dosage Forms. Pharm Res [Internet]. 2018;36(1):16. Available from: https://doi.org/10.1007/s11095-018-2547-6
4. Dumpala R, Patil C. A Review on Solid Oral Dosage Forms with an Industrial Perspective for Process Validation. 2020 Oct 17;4:8. 
5. Awad A, Trenfield SJ, Basit AW. Chapter 19 - Solid oral dosage forms. In: Adejare ABT-R (Twenty-third E, editor. Academic Press; 2021. p. 333–58. 
6. Martin’s. physical pharmacy and pharmaceutical science. 2009. 
7. Henness S, Keam SJ. Vildagliptin. Drugs [Internet]. 2006;66(15):1989–2001. 
8. Stamataros G, Schneider SH. Vildagliptin in the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother. 2011 Aug;12(12):1967–73. 
9. Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to Diabetes Mellitus BT  - Diabetes: An Old Disease, a New Insight. In: Ahmad SI, editor. New York, NY: Springer New York; 2013. p. 1–11. 
10. Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2019;127(Suppl 1):S1–7. 
11. Mogensen CE. Diabetes mellitus and the kidney. Kidney Int [Internet]. 1982;21(5):673–5. Available from: http://dx.doi.org/10.1038/ki.1982.79
12. Chauhan M, Patel SA, Patel SK. A Concise Review on Sustained Drug Delivery System and Its Opportunities. In 2012. 
13. Ankit B, R.P.S. R, Y.S. T, Bhaduka G. GS. Oral sustained release dosage form: an opportunity to prolong the release of drug. Int J Adv Res Pharm Bio Sci [Internet]. 2013 Aug 
14. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy [Internet]. Lippincott Williams & Wilkins; 1970. 
15. Kumar P, Desu PK, Vaishnavi G, Divya K, Lakshmi U, Kumar DP. An Overview on Preformulation Studies. Indo Am J Pharmacetical Sci. 2015;2(10):1399–407. 
16. Baratam SR, Harsha MV. Preparation and Characterisation of Sustained Released Dosage Form for Ketoprofen using Natural Gums. Int J Pharm Investig. 2020 Mar 14;10(1):54–8. 
17. Hima AVS, Bhavya G, Padmalatha K. Pharmaceutical sciences formulation and in vitro evaluation of vildagliptin floating tablets. (07):136–45. 
18. Dwivedi C, Rao SP, Roy A, Saraf S, Kulsum U, Verma N, et al. Formulation and characterization of metformin hydrochloride sustained release matrix tablet containing cassia tora mucilage. J drug deliv ther. 2017 nov 15;7(6). 
19. Ganesh Kumar Y, Sreekanth J, Satyavati D, Kumar MYG. Formulation Development and Evaluation of Sustained Release Matrix Tablets of Vildagliptin-Synthetic and Natural Polymers. Vol. 9, Asian Journal of Pharmaceuticc. 
20. Nikhilitha P. Effect of natural polymer on release retarding rate of glimepiride sustained release tablet. J Adv Sci Res. 2021;12(01 Suppl 1):145–50. 
21. Krishnarajan D, Reddy CM, Kanikanti S, Kumar NS, Purushothaman M. Formulation and evaluation of sustained release matrix tablets of levofloxacin using natural polymer. Pharmacophore [Internet]. 2013;4(5):146.